Shares of Abcam plc (OTCMKTS:ABCZF – Get Rating) were up 13% on Tuesday . The company traded as high as 15.80 and last traded at 15.80. Approximately 200 shares changed hands during trading, a decline of 86% from the average daily volume of 1,392 shares. The stock had previously closed at 13.99.
Abcam Stock Performance
The business has a 50-day moving average price of 14.41 and a two-hundred day moving average price of 15.38.
About Abcam
(Get Rating)
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools.
Further Reading
- Get a free copy of the StockNews.com research report on Abcam (ABCZF)
- Roku Stock is Down but Not Out
- If You're Hungry for Value, Take a Bite on Ruth's Hospitality Grp
- Is Ford Rolling To A Rebound After Its Q3 Warning
- Has AMD stock stock fallen too far?
- Oracle's Short-Term Pain Could Be Your Long-Term Gain
Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.